AI English summary of an SEC filing — figures as filed
The company said its Board of Directors appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a director, effective June 9, June 9, 2025.
Key points
AI summaryThe company said its Board of Directors appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a director, effective June 9, June 9, 2025.
Procter & Gamble said Arnold will serve on the Audit and Compensation & Leadership Development Committees. It said the board determined he is independent under the NYSE listing standards and the company's Independence Guidelines.
The company said Arnold will receive the same compensation as the other non-employee directors, including a pro-rated annual RSU grant reflecting his appointment date in June. It said the company's director compensation program is described in its definitive proxy statement dated August 23, 2024.
In its news release, the company said Arnold led Eaton from 2016 to May 2025, currently serves as lead independent board director of Medtronic, Inc., and began his career at General Electric.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Craig Arnold Appointed to Board
The company said its Board of Directors appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a director, effective June 9, June 9, 2025.
Source · Based on the filing body and exhibits
Committee Assignments and Independence Determination
Procter & Gamble said Arnold will serve on the Audit and Compensation & Leadership Development Committees. It said the board determined he is independent under the NYSE listing standards and the company's Independence Guidelines.
Source · Based on the filing body and exhibits
Director Compensation Terms
The company said Arnold will receive the same compensation as the other non-employee directors, including a pro-rated annual RSU grant reflecting his appointment date in June. It said the company's director compensation program is described in its definitive proxy statement dated August 23, 2024.
Source · Based on the filing body and exhibits
Arnold's Career and Current Role
In its news release, the company said Arnold led Eaton from 2016 to May 2025, currently serves as lead independent board director of Medtronic, Inc., and began his career at General Electric.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…